Mutation of c-Met RTK: A novel molecular therapeutic target for the treatment of mesothelioma

被引：0
|
作者：
Jagadeeswaran, Ramasamy
Ma, Patrick C.
Seiwert, Tanguy Y.
Jagadeeswaran, Sujatha
Zumba, Osvaldo
Nallasura, Vidya
Ahmed, Salman
Kratzke, Robert A.
Gordon, Gavin J.
Sugarbaker, David J.
Bueno, Raphael
Janamanchi, Varalakshmi
Bindokas, Vytas P.
Kindler, Hedy L.
Salgia, Ravi
机构：
[1] Univ Chicago, Sect Hematol Oncol, Canc Res Ctr, Dept Med,Med Ctr,Pritzker Sch Med, Chicago, IL 60637 USA
[2] Univ Minnesota, Sch Med, Dept Surg, Div Cardiovasc & Thorac Surg, Minneapolis, MN 55455 USA
[3] Harvard Med Sch, Brigham & Womens Hosp, Dana Farber Canc Inst, Dept Surg,Div Thorac Surg, Boston, MA USA
来源：
CANCER RESEARCH | 2006年 / 66卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3028
引用
收藏
页数：2
相关论文
共 50 条
  • [1] c-Met receptor tyrosine kinase: A novel molecular therapeutic target for the treatment of pancreatic cancer
    Jagadeeswaran, Ramasamy
    Ahmed, Salman
    Janamanchi, Varalakshmi
    Surawska, Hanna
    Karikari, Collins
    Maitra, Anirban
    Salgia, Ravi
    CANCER RESEARCH, 2006, 66 (08)
  • [2] C-MET as a new therapeutic target for the development of novel anticancer drugs
    Israel Cañadas
    Federico Rojo
    Montserrat Arumí-Uría
    Ana Rovira
    Joan Albanell
    Edurne Arriola
    Clinical and Translational Oncology, 2010, 12 : 253 - 260
  • [3] C-MET as a new therapeutic target for the development of novel anticancer drugs
    Canadas, Israel
    Rojo, Federico
    Arumi-Uria, Montserrat
    Rovira, Ana
    Albanell, Joan
    Arriola, Edurne
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2010, 12 (04): : 253 - 260
  • [4] c-Met is a potentially new therapeutic target for treatment of human melanoma
    Puri, Neelu
    Ahmed, Salman
    Janamanchi, Varalakshmi
    Tretiakova, Maria
    Zumba, Osvaldo
    Krausz, Thomas
    Jagadeeswaran, Ramasamy
    Salgia, Ravi
    CLINICAL CANCER RESEARCH, 2007, 13 (07) : 2246 - 2253
  • [5] The role of c-Met in mesothelioma
    Ramasamy, J.
    Zumba, O.
    Kindler, H. L.
    Salgia, R.
    LUNG CANCER, 2006, 54 : S53 - S53
  • [6] Identification of c-Met as downstream of γ-glutamylcyclotransferase (GGCT), a novel therapeutic target for cancer
    Taniguchi, Keiko
    Saito, Yumiko
    Ii, Hiromi
    Horinaka, Mano
    Kageyama, Susumu
    Nakata, Susumu
    Ukimura, Osamu
    Sakai, Toshiyuki
    CANCER SCIENCE, 2025, 116 : 159 - 159
  • [7] Identification of c-Met as a novel target of γ-glutamylcyclotransferase
    Saito, Yumiko
    Taniguchi, Keiko
    Ii, Hiromi
    Horinaka, Mano
    Kageyama, Susumu
    Nakata, Susumu
    Ukimura, Osamu
    Sakai, Toshiyuki
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [8] Identification of c-Met as a novel target of γ-glutamylcyclotransferase
    Yumiko Saito
    Keiko Taniguchi
    Hiromi Ii
    Mano Horinaka
    Susumu Kageyama
    Susumu Nakata
    Osamu Ukimura
    Toshiyuki Sakai
    Scientific Reports, 13
  • [9] c-Met: A Promising Therapeutic Target in Bladder Cancer
    Feng, Yanfei
    Yang, Zitong
    Xu, Xin
    CANCER MANAGEMENT AND RESEARCH, 2022, 14 : 2379 - 2388
  • [10] Activated c-Met; a Potential Therapeutic Target in Chordoma
    Riddle, Nicole
    Jones, Krister
    Staddon, Arthur
    Zhang, Paul
    Brooks, John
    Huang, Jui-Han
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2012, 138 : A303 - A303
12345